Do Antiphospholipid Antibodies Interfere with Tissue Factor Pathway Inhibitor? - Isotype distribution and clinical significance in a series of 92 patients

By Jacobsen E.M.   Sandset P.M.   Wisloff F.  

Thrombosis Research, Vol. 94, Iss. 4, 1999-05 ,pp. : 213-220

Elsevier

Access to resources Recommend Favorite

Anticardiolipin and anti-β₂GPI antibodies in a large series of European patients with systemic lupus erythematosus: Prevalence and clinical associations

By Domenico Sebastiani Gian   Galeazzi Mauro   Tincani Angela   Piette Jean-Charles   Font Josep   Allegri Flavio   Mathieu Alessandro   Smolen Josef   de Ramon Garrido Enrique   Fernandez-Nebro Antonio   Jedryka-Goral Anna   Papasteriades Chryssa   Morozzi Gabriella   Bellisai Francesca   De Pita Ornella   Marcolongo Roberto  

Scandinavian Journal of Rheumatology, Vol. 28, Iss. 6, 1999-12 ,pp. : 344-351

Informa Healthcare

Access to resources Recommend Favorite

Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?

By Sahin Mehmet   Duzgun Nursen   Tunc Sevket   Tutkak Huseyin  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 154-160

Springer Publishing Company

Access to resources Recommend Favorite

Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays

By Tsutsumi Akito   Hayashi Taichi   Chino Yusuke   Mamura Mizuko   Goto Daisuke   Matsumoto Isao   Ito Satoshi   Sumida Takayuki  

Modern Rheumatology, Vol. 16, Iss. 3, 2006-06 ,pp. : 158-164

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Description of Seizures in Patients with Systemic Lupus Erythematosus

By  

European Neurology, Vol. 59, Iss. 6, 2008-04 ,pp. : 320-323

Karger

Access to resources Recommend Favorite